Billy Evans, partner of convicted fraudster Elizabeth Holmes, has launched a new blood testing startup named Haemanthus, which employs novel technology distinct from Holmesâ failed Theranos. Haemanthus uses Raman spectroscopy and AI to analyze samples, beginning with veterinary applications. The company emphasized that Holmes has no role in its operations, seeking to establish credibility by differentiating itself from Theranos. The approach aims to utilize light to read complex biological fluids, offering insights into health that traditional testing methods cannot detect.
Haemanthus stated, "Skepticism is rational. Elizabeth Holmes has zero involvement in Haemanthus. This is not Theranos 2.0."
Collection
[
|
...
]